Literature DB >> 32008667

The Placenta as a Window to Maternal Vascular Health.

W Tony Parks1, Janet M Catov2.   

Abstract

Cardiovascular disease remains the leading killer of women, with sex-specific manifestation, mechanisms, and morbidity. Preeclampsia, fetal growth restriction, and a subset of preterm births demonstrate aberrancies in the maternal vessels supplying the placenta and damage to the placental parenchyma consistent with hypoxic/ischemic or oxidative injury. This constellation of findings, maternal vascular malperfusion (MVM) lesions, may hold the key to understanding and identifying the elevated risk for early cardiovascular disease in women who experience adverse pregnancy outcomes. This intriguing possibility has only begun to be examined, but accumulating evidence is compelling and is reviewed here.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular; Maternal vascular malperfusion; Placenta; Women

Mesh:

Year:  2019        PMID: 32008667     DOI: 10.1016/j.ogc.2019.10.001

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  7 in total

1.  Sex Differences Across the Lifespan: A Focus on Cardiometabolism.

Authors:  T Rajendra Kumar; Jane E B Reusch; Wendy M Kohrt; Judith G Regensteiner
Journal:  J Womens Health (Larchmt)       Date:  2020-05-17       Impact factor: 2.681

2.  Angiogenic factors and prediction for ischemic placental disease in future pregnancies.

Authors:  Katherine M Johnson; Laura Smith; Anna M Modest; Saira Salahuddin; S A Karumanchi; Sarosh Rana; Brett C Young
Journal:  Pregnancy Hypertens       Date:  2021-05-14       Impact factor: 2.494

Review 3.  A Message from the Human Placenta: Structural and Immunomodulatory Defense against SARS-CoV-2.

Authors:  Nina-Naomi Kreis; Andreas Ritter; Frank Louwen; Juping Yuan
Journal:  Cells       Date:  2020-07-25       Impact factor: 6.600

Review 4.  Acute Atherosis Lesions at the Fetal-Maternal Border: Current Knowledge and Implications for Maternal Cardiovascular Health.

Authors:  Daniel Pitz Jacobsen; Heidi Elisabeth Fjeldstad; Guro Mørk Johnsen; Ingrid Knutsdotter Fosheim; Kjartan Moe; Patji Alnæs-Katjavivi; Ralf Dechend; Meryam Sugulle; Anne Cathrine Staff
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

Review 5.  The Pivotal Role of the Placenta in Normal and Pathological Pregnancies: A Focus on Preeclampsia, Fetal Growth Restriction, and Maternal Chronic Venous Disease.

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Cielo García-Montero; Miguel A Sáez; Miguel Angel Álvarez-Mon; Diego Torres-Carranza; Melchor Álvarez-Mon; Julia Bujan; Natalio García-Honduvilla; Coral Bravo; Luis G Guijarro; Juan A De León-Luis
Journal:  Cells       Date:  2022-02-06       Impact factor: 6.600

6.  Placental Pathology as a Tool to Identify Women for Postpartum Cardiovascular Risk Screening following Preeclampsia: A Preliminary Investigation.

Authors:  Samantha J Benton; Erika E Mery; David Grynspan; Laura M Gaudet; Graeme N Smith; Shannon A Bainbridge
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

7.  APPLAUSE: Automatic Prediction of PLAcental health via U-net Segmentation and statistical Evaluation.

Authors:  Maximilian Pietsch; Alison Ho; Alessia Bardanzellu; Aya Mutaz Ahmad Zeidan; Lucy C Chappell; Joseph V Hajnal; Mary Rutherford; Jana Hutter
Journal:  Med Image Anal       Date:  2021-06-23       Impact factor: 8.545

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.